AuntMinnie

APRIL 15, 2024

FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of Nuclear Medicine. FAPI-PET either confirmed or ruled out the disease in all cases, the group found.

Nuclear Medicine 122

Nuclear Medicine PET Scan Hospital Clinic 122

AuntMinnie

OCTOBER 25, 2024

His research interests include using structural and functional MRI -- particularly ultrahigh-field, 7-tesla MRI -- to map brain microstructure and develop neurosurgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia. Dmitry Beyder.

Nuclear Medicine 143

Nuclear Medicine Education Radiation Science Radiology Technologist 143

Imaging Technology

JUNE 29, 2023

christine.book Thu, 06/29/2023 - 12:17 June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, SNMMI 2023 , found that personalized dosing of men with prostate cancer resulted in improved patient outcomes. Approved by the U.S. Patients at St.

Nuclear Medicine 98

Nuclear Medicine Hospital Disease Clinic 98

AuntMinnie

APRIL 4, 2024

Thomas Hope, MD, a radiologist and nuclear medicine physician at the University of California, San Francisco (UCSF), said that approval of lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA) radioligand has driven a marked interest and excitement about theranostics and radioligand therapies (RLT). Hope added.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

Imaging Technology

JUNE 28, 2023

milla1cf Wed, 06/28/2023 - 20:28 June 28, 2023 — GE HealthCare is set to unveil SIGNA PET/MR AIR [i] , at the Society of Nuclear Medicine and Molecular Imaging ( SNMMI) 2023 annual meeting. The recent approval of drugs with disease modifying potential require additional imaging of patients with both MR and PET. Feb 3, 2022.

Healthcare 98

Healthcare Healthcare Disease Nuclear Medicine 98

Imaging Technology

JUNE 19, 2023

Dr. Scholz joined NorthStar in 2021, and was promoted to President and Chief Operating Officer (COO) in 2022. Our fast-growing portfolio encompasses promising therapeutic radioisotopes, specialty SPECT imaging agents and collaborative research for the use of therapeutic radiopharmaceuticals to treat a range of potential disease states.

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

Imaging Technology

JULY 26, 2023

The findings are described in European Urology and were presented at the American Society of Clinical Oncology and Society of Nuclear Medicine & Molecular Imaging annual meetings in 2022. For more information: [link] Wednesday, July 26, 2023 - 20:36

Nuclear Medicine 97

Nuclear Medicine Imaging Disease Clinic 97

Imaging Technology

MAY 31, 2023

“We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Flavio Forrer , MD, PhD, Chairman of Nuclear Medicine in the Division of Radiology and Nuclear Medicine at Kantonsspital St. Gallen in Switzerland [vii].

Nuclear Medicine 98

Nuclear Medicine Healthcare Healthcare IT 98

Imaging Technology

APRIL 3, 2023

These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In Mr. Merrick concluded, “This is a very exciting and dynamic time for NorthStar and all those involved in nuclear medicine. Mo-99 production without the use of uranium.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

AuntMinnie

NOVEMBER 12, 2024

Middlebrooks' research interest consists of using ultrahigh-field, 7-tesla MRI to plot brain microstructure and develop surgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia.

Radiologist 144

Radiologist Education Clinic Radiology 144

Imaging Technology

OCTOBER 4, 2024

As Theranostics and the use of radiopharmaceutical therapy (RPT) to treat cancer and other diseases have become more prevalent, interest in using dosimetry to personalize RPT treatments has grown. 2022 Oct;63(10):1467-1474. v MIM SurePlan MRT is also trusted globally, with installations in 23 countries spanning four continents.

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiation Healthcare 52

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

JUNE 27, 2023

Urbain, MD, PhD, FASNC , professor of radiology/nuclear medicine and medicine, vice chair of theranostics, and director of nuclear medicine at Roswell Park Cancer Center at the University of Buffalo , Buffalo, New York. and ‘How can we ensure diversity in all parts of the nuclear medicine family?’

Nuclear Medicine 115

Nuclear Medicine Imaging Hospital Radiology 115

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Traditional treatments didn't slow the disease in these patients, noted UT’s Vroman.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52